ACTH-producing pituitary gland neoplasm
disease diseaseOn this page
Also known as ACTH producing pituitary gland neoplasmACTH-producing pituitary neoplasmACTH-producing pituitary tumorACTH-producing pituitary tumourACTH-secreting tumor of pituitaryACTH-secreting tumor of the pituitaryACTH-secreting tumour of pituitaryACTH-secreting tumour of the pituitaryadrenocorticotropin producing pituitary gland tumoradrenocorticotropin producing pituitary gland tumouradrenocorticotropin secreting neoplasm of pituitaryadrenocorticotropin secreting neoplasm of the pituitaryadrenocorticotropin secreting pituitary gland tumoradrenocorticotropin secreting pituitary gland tumouradrenocorticotropin secreting tumor of pituitaryadrenocorticotropin secreting tumor of the pituitaryadrenocorticotropin secreting tumour of pituitaryadrenocorticotropin secreting tumour of the pituitarycorticotropin secreting pituitary gland neoplasm
Summary
ACTH-producing pituitary gland neoplasm (MONDO:0045058) is a cancer and 2 clinical trials. A subtype of pituitary tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 2
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | ACTH-producing pituitary gland neoplasm |
| Mondo ID | MONDO:0045058 |
| NCIT | C7909 |
| UMLS | C0278862 |
| MedGen | 82997 |
| GARD | 0025940 |
| Anatomy (UBERON) | UBERON:0000007 |
| Is cancer (heuristic) | yes |
Also known as: ACTH producing pituitary gland neoplasm · ACTH-producing pituitary gland neoplasm · ACTH-producing pituitary neoplasm · ACTH-producing pituitary tumor · ACTH-producing pituitary tumour · ACTH-secreting tumor of pituitary · ACTH-secreting tumor of the pituitary · ACTH-secreting tumour of pituitary · ACTH-secreting tumour of the pituitary · adrenocorticotropin producing pituitary gland tumor · adrenocorticotropin producing pituitary gland tumour · adrenocorticotropin secreting neoplasm of pituitary · adrenocorticotropin secreting neoplasm of the pituitary · adrenocorticotropin secreting pituitary gland tumor · adrenocorticotropin secreting pituitary gland tumour · adrenocorticotropin secreting tumor of pituitary · adrenocorticotropin secreting tumor of the pituitary · adrenocorticotropin secreting tumour of pituitary · adrenocorticotropin secreting tumour of the pituitary · corticotropin secreting pituitary gland neoplasm (+3 more)
Disease family
This is a subtype of pituitary tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › endocrine gland neoplasm › pituitary tumor › ACTH-producing pituitary gland neoplasm
Related subtypes (8): pituitary cancer, posterior pituitary gland neoplasm, prolactin producing pituitary tumor, non-functioning pituitary gland neoplasm, functioning pituitary gland neoplasm, pituitary gland adenoma, growth hormone-producing pituitary gland neoplasm, benign neoplasm of pituitary gland
Subtypes (2): ACTH-producing pituitary gland adenoma, ACTH-producing pituitary gland carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 2.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE2 | 1 |
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02749227 | PHASE2 | TERMINATED | Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors |
| NCT07463625 | Not specified | RECRUITING | Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.